Deep Convolutional Neural Networks With Ensemble Learning and Generative Adversarial Networks for Alzheimer's Disease...

Area of Science:

• Neuroscience and Medical Imaging
• Artificial Intelligence in Healthcare

Background:

• Alzheimer's disease (AD) is a leading cause of dementia, necessitating early detection methods.
• Non-invasive neuroimaging techniques like MRI and PET are crucial for identifying AD pathogenesis.
• Deep learning (DL) offers advanced analytical capabilities for complex healthcare datasets.

Purpose of the Study:

• To review interdisciplinary approaches for the early detection of Alzheimer's disease.
• To explore recent advances in AD classification using 3D CNNs with multi-modal PET/MRI data.
• To discuss the application of GANs and ensemble learning (EL) to enhance DL model performance.

Main Methods:

• Utilizing 3D Convolutional Neural Networks (CNNs) for multi-modal PET/MRI data analysis.
• Applying Generative Adversarial Networks (GANs) to address challenges of limited neuroimaging data.
• Integrating Ensemble Learning (EL) techniques to improve the robustness of CNN models.

Main Results:

• 3D CNN architectures demonstrate significant potential for classifying Alzheimer's disease from neuroimaging.
• GANs can effectively augment datasets, mitigating issues related to data scarcity in AD research.
• Ensemble learning enhances the reliability and accuracy of deep learning models for AD detection.

Conclusions:

• Deep learning, particularly 3D CNNs, offers a promising avenue for early Alzheimer's disease detection.
• Multi-modal neuroimaging data combined with advanced DL techniques can improve diagnostic accuracy.
• Further research into GANs and EL integration is vital for robust, data-efficient AD classification.